Clinical Trial Update: A Clinical Evidence Study Evaluating Quality of Life Parameters Following Treatment With Robitussin [Phase 4]

View source ↗

Summary

A Phase 4 study evaluated quality-of-life outcomes after Robitussin treatment in individuals with a common cold or cough. The results have been posted from the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Cold
• Cough

Drugs mentioned

• Robitussin (dextromethorphan and guaifenesin)

Snippet

Sponsor: HALEON | Conditions: Common Cold, Cough | Phase 4 | Status: COMPLETED | Results posted: 2026-02-20